HarrisMartin's Cyber Monday Event is Going on NOW! All Annual Subscriptions are 30% off; 6-Month Subscriptions are 10% off. Discount already removed from prices online. Don't wait - this discount is available for one day only - SUBSCRIBE HERE!
Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 86
11th Cir. Affirms Decision to Exclude Testimony Linking Remicade, Lung Injury
Drugs & Medical Devices - Issue: 85
Calif. Sup. Ct. Refuses to Review Wyeth-Generic Duty-to-Warn Ruling
Merck: FDA Statement Supports Preemption, Dismissal of Vytorin Claims
Judge Says Revised Accutane Warning is Too 'Ambiguous'
Parties Trade Briefs on Plan to Resolve Prempro MDL
Celebrex Plaintiff Can't Proceed with Legal Malpractice Claim
Eli Lilly Announces $1.4 Billion Settlement of Zyprexa Off-Label Claims
Judge Holds Firm on Dismissal of Fraud Claims from Chantix Suit
